Advertisement
Advertisement

CRIS

CRIS logo

Curis Inc

0.56
USD
Sponsored
-0.02
-2.77%
May 08, 15:57 UTC -4
Closed
exchange

After-Market

0.59

+0.03
+4.99%

CRIS Earnings Reports

Positive Surprise Ratio

CRIS beat 21 of 36 last estimates.

58%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.91M
/
-$0.45
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
+5.75%
/
-33.82%

Curis Inc earnings per share and revenue

On May 04, 2026, CRIS reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.40 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.52 million, with a --% difference.
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.45 USD, with revenue projected to reach 2.91 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
logo
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
logo
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
logo
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
logo
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
logo
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
logo
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
logo
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
logo
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
logo
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
For Q1 2026, Curis Inc reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 4 analysts, Curis Inc is expected to report EPS of -$0.45 and revenue of $2.91M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement